AnaptysBio, Inc (ANAB) stock
ANABNasdaqPharmaceutical PreparationsFiscal year ends June 30
$49.24+2.63 (+5.64%)
Close on Oct 19, 2026Market cap $2.28BP/E –Yield –
AnaptysBio total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
No total debt figures for AnaptysBio
AnaptysBio has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?